| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/13/2005 | CA2530866A1 Methods and compositions for treating disorders of the extracellular matrix |
| 01/13/2005 | CA2530623A1 Assay for detecting atrial and brain natriuretic peptide prohormones |
| 01/13/2005 | CA2530480A1 Conjugated complement cascade inhibitors |
| 01/13/2005 | CA2529510A1 Sirt1 modulators for manipulating cells/organism lifespan/stress response |
| 01/13/2005 | CA2529318A1 Methods of inhibiting vascular permeability and apoptosis |
| 01/12/2005 | EP1496057A1 Novel crystal of quinoxalinedione derivative anhydride |
| 01/12/2005 | EP1496054A1 Medicinal composition for improving angiotension-regulating function of blood vessel endothelium |
| 01/12/2005 | EP1495765A1 Composition for preventing arteriosclerosis |
| 01/12/2005 | EP1495759A1 Solid dispersion composition |
| 01/12/2005 | EP1495756A1 Severe sepsis preventive therapeutic agent |
| 01/12/2005 | EP1495111A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 01/12/2005 | EP1495031A1 Labeled oxazinocarbazoles as diagnostic agents |
| 01/12/2005 | EP1495023A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 01/12/2005 | EP1495022A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 01/12/2005 | EP1495020A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases |
| 01/12/2005 | EP1495018A1 Tricyclic thrombin receptor antagonists |
| 01/12/2005 | EP1495016A2 Heterocyclic compounds and their use as modulators of p38 map kinase |
| 01/12/2005 | EP1495009A2 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 01/12/2005 | EP1495005A1 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494999A1 Occlusive composition comprising a poly(2-cyanoacrylate) monomer |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494992A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494704A1 Glp-1 agonist and cardiovascular complications |
| 01/12/2005 | EP1494698A2 Compositions and methods for treating and preventing necrosis |
| 01/12/2005 | EP1494691A2 Treatment of diseases involving defective gap junctional communication |
| 01/12/2005 | EP1494685A1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside |
| 01/12/2005 | EP1494677A1 Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction |
| 01/12/2005 | EP1494674A1 Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers |
| 01/12/2005 | EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity |
| 01/12/2005 | EP1494671A1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494662A1 Tnp-470 polymer conjugates and use thereof |
| 01/12/2005 | EP1494659A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt |
| 01/12/2005 | EP1494658A1 Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases |
| 01/12/2005 | EP1494536A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 01/12/2005 | EP1494535A2 Compositions and minimally invasive methods for treating incomplete tissue repair |
| 01/12/2005 | EP1494530A2 Combination therapy using trefoil peptides |
| 01/12/2005 | EP1443970A4 Promoters exhibiting endothelial cell specificity and methods of using same |
| 01/12/2005 | EP1381605B1 Mercaptoacetylamide derivatives, a process for their preparation and their use |
| 01/12/2005 | EP1353918B1 Morpholine derivatives as antagonists of orexin receptors |
| 01/12/2005 | EP1307216A4 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/12/2005 | EP1299383B1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/12/2005 | EP1227734B1 Compositions comprising edible oils or fats and phytosterols and/or phytostanols dissolved therein |
| 01/12/2005 | EP1183254B1 Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 01/12/2005 | EP1150680B1 Use of moxonidine for postmyocardial infarction treatment |
| 01/12/2005 | EP1105370B9 Novel aryl sulphonamides and analogues |
| 01/12/2005 | EP1063987A4 Dietary control of arachidonic acid metabolism |
| 01/12/2005 | EP1030851B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/12/2005 | EP0991628B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES |
| 01/12/2005 | EP0944604B1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/12/2005 | CN1564821A 5-methoxy-8-aryl-[1, 2, 4]triazolo[1, 5-a]pyridine derivatives as adenosine receptor antagonists |
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1564816A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2005 | CN1564796A Stabilized compositions of aqueous reduced coenzyme Q solution |
| 01/12/2005 | CN1564696A Compositions for and methods of treating and preventing sirs/sepsis |
| 01/12/2005 | CN1564695A Pharmaceutical formulation |
| 01/12/2005 | CN1564689A Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 01/12/2005 | CN1564688A Methods of treating pulmonary disease |
| 01/12/2005 | CN1564687A Use of phosphodiesterase IV inhibitors |
| 01/12/2005 | CN1564686A 8-amino- [1, 2, 4]triazolo [1, 5-a]pyridine-6-carboxylic acid amide |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1563404A Method for preparing decrease blood pressure peptide 'Angiotensin I-converting enzyme inhibitor' of rice bran protein |
| 01/12/2005 | CN1563387A Gene of earthworm plasmin and genetic engineerng strain, construction and application |
| 01/12/2005 | CN1563353A Strain of Pichia yeast genetic engineering, preparation method and application |
| 01/12/2005 | CN1563028A Flavonoid extract product containing pedaliin and application |
| 01/12/2005 | CN1562992A Technique for extracting general coumarin and monomer components from cnidium fruit and medicinal preparation |
| 01/12/2005 | CN1562970A PPAR full activator of amino acids of aralkyl possessing excellent activity for lowering sugar and ester |
| 01/12/2005 | CN1562369A Combination of medication for curing high blood pressure |
| 01/12/2005 | CN1562358A Peroral enteric coated capsule of defibrase |
| 01/12/2005 | CN1562349A Bacterin of nucleic acid for anti atherosclerosis and preparation method |
| 01/12/2005 | CN1562339A Method for preparing pharmaceutics of hydrolysate of brain protein |
| 01/12/2005 | CN1562336A Solid effervesce decoction pieces from ganoderma lucidum |
| 01/12/2005 | CN1562305A Chinese traditional medicine for treating cerebral thrombosis, preparation method and application |
| 01/12/2005 | CN1562304A Chinese traditional medicine of clearing away hear-fire and cultivating mentality for curing excitability cardiovasular injury |
| 01/12/2005 | CN1562294A Combination of Chinese traditional medicine of bactericidin for curing crissum disease |
| 01/12/2005 | CN1562285A Combination of active constituent of Chinese traditional medicine for curing cardiovascular and cerebrovascular diseases and preparation method |
| 01/12/2005 | CN1562276A Application of anemarrhena extract in preparing mediciation for preventing and curing abnormal rapidity heart rate and essential hyperension |
| 01/12/2005 | CN1562257A Health protection medicine for preventing cardiovascular and cerebrovascular diseases |
| 01/12/2005 | CN1562230A Medication for curing cardiovascular disease |
| 01/12/2005 | CN1562216A Preparation of Chinese traditional medicine for curing cardiovascular and cerebrovascular disease and preparation method |
| 01/12/2005 | CN1562186A Preparation of Chinese traditional medicine for curing Illness of Cardiac cerebral ischemia and preparation method |
| 01/12/2005 | CN1562166A Compound preparation composed of extract of Chinese traditional medicine and borneol, and preparation method |
| 01/12/2005 | CN1562153A Method for preparing Herba Lycopi extract with anti-oxygen dificit function |
| 01/12/2005 | CN1562147A Radix scutellariae extract freeze-dried powder injection and its preparing method |
| 01/12/2005 | CN1562145A Guangsheng hemp extract, its preparing method and use |
| 01/12/2005 | CN1562118A Chinese medicinal preparation for treating coronary heart disease, cerebral thrombus and cerebral infarct |
| 01/12/2005 | CN1562109A Multifunction health therapeutic external use liquid |
| 01/12/2005 | CN1562097A Fructus choerospondiatis freeze-drying powder injection and its preparing method |
| 01/12/2005 | CN1562095A Hawthorn essence defatting dripping pill and preparing method and its use |
| 01/12/2005 | CN1562094A Hawthorn essence defatting soft capsule preparing method and its use |
| 01/12/2005 | CN1562093A Method for preparing mailuoning freeze-dried powder for injection |
| 01/12/2005 | CN1562081A Process for preparing livestock animal brain fat composite medicine |
| 01/12/2005 | CN1562073A Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/12/2005 | CN1562072A Powder injection of medium and/or low molecular weight chondroitin sulfate |
| 01/12/2005 | CN1562064A New use of saponin compound for treating cardiovascular disease |
| 01/12/2005 | CN1562062A Kakonein solid dispersion and its preparing method |
| 01/12/2005 | CN1562060A Haw leaf total flavone oral disintegration tablet and its preparing method |